These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24753748)

  • 1. MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer.
    Li J; Li X; Kong X; Luo Q; Zhang J; Fang L
    Int J Clin Exp Med; 2014; 7(3):558-65. PubMed ID: 24753748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.
    Li J; Kong X; Zhang J; Luo Q; Li X; Fang L
    Cancer Cell Int; 2013 Feb; 13(1):7. PubMed ID: 23374284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.
    Li XY; Luo QF; Wei CK; Li DF; Li J; Fang L
    Int J Clin Exp Med; 2014; 7(1):32-40. PubMed ID: 24482686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma.
    Zhang JF; Zhang JS; Zhao ZH; Yang PB; Ji SF; Li N; Shi QD; Tan J; Xu X; Xu CB; Zhao LY
    Cancer Cell Int; 2018; 18():195. PubMed ID: 30524203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop.
    Xu T; Xie M; Jing X; Jiang H; Wu X; Wang X; Shu Y
    J Transl Med; 2023 Feb; 21(1):77. PubMed ID: 36737782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,4,5,6,7,8‑Hexahydropyrido[4,3‑d]pyrimidine inhibits HepG2 cell proliferation, migration and invasion, and induces apoptosis through the upregulation of miR‑26b‑5p by targeting CDK8.
    Luo H; Yang Y; Zhou Y; Bai X; Hou Y
    Oncol Lett; 2023 Jun; 25(6):260. PubMed ID: 37205919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
    Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
    Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lncRNA TATDN1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Regulating miR-26b Methylation.
    Long Q; Li H; Fan Y; Zhang J
    Cancer Manag Res; 2020; 12():11403-11410. PubMed ID: 33192097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.
    Song W; Wu S; Wu Q; Zhou L; Yu L; Zhu B; Gong X
    J Cell Biochem; 2019 Aug; 120(8):14095-14106. PubMed ID: 31087707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
    Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
    Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-26b regulates cancer proliferation migration and cell cycle transition by suppressing TRAF5 in esophageal squamous cell carcinoma.
    Chen Z; Zhao L; Zhao F; Yang G; Wang J
    Am J Transl Res; 2016; 8(5):1957-70. PubMed ID: 27347306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
    Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.
    He SB; Yuan Y; Wang L; Yu MJ; Zhu YB; Zhu XG
    J Exp Clin Cancer Res; 2011 Nov; 30(1):109. PubMed ID: 22104393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppressive microRNA-195-5p regulates cell growth and inhibits cell cycle by targeting cyclin dependent kinase 8 in colon cancer.
    Luo Q; Zhang Z; Dai Z; Basnet S; Li S; Xu B; Ge H
    Am J Transl Res; 2016; 8(5):2088-96. PubMed ID: 27347317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-26b regulates cartilage differentiation of bone marrow mesenchymal stem cells in rats through the Wnt/β-catenin signaling pathway.
    Huang T; Zhou Y; Wang J; Cao Y; Hang DH
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5084-5092. PubMed ID: 31298408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells.
    Hua K; Yang W; Song H; Song J; Wei C; Li D; Fang L
    Int J Clin Exp Med; 2015; 8(8):12018-27. PubMed ID: 26550114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 20. MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
    Zhao X; He W; Li J; Huang S; Wan X; Luo H; Wu D
    Am J Transl Res; 2015; 7(11):2346-54. PubMed ID: 26807182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.